130 related articles for article (PubMed ID: 8057290)
1. Oxadiazoles as ester bioisosteric replacements in compounds related to disoxaril. Antirhinovirus activity.
Diana GD; Volkots DL; Nitz TJ; Bailey TR; Long MA; Vescio N; Aldous S; Pevear DC; Dutko FJ
J Med Chem; 1994 Jul; 37(15):2421-36. PubMed ID: 8057290
[TBL] [Abstract][Full Text] [Related]
2. Antipicornavirus activity of tetrazole analogues related to disoxaril.
Diana GD; Cutcliffe D; Volkots DL; Mallamo JP; Bailey TR; Vescio N; Oglesby RC; Nitz TJ; Wetzel J; Giranda V
J Med Chem; 1993 Oct; 36(22):3240-50. PubMed ID: 8230114
[TBL] [Abstract][Full Text] [Related]
3. Conformationally restricted analogues of disoxaril: a comparison of the activity against human rhinovirus types 14 and 1A.
Mallamo JP; Diana GD; Pevear DC; Dutko FJ; Chapman MS; Kim KH; Minor I; Oliveira M; Rossmann MG
J Med Chem; 1992 Dec; 35(25):4690-5. PubMed ID: 1335081
[TBL] [Abstract][Full Text] [Related]
4. Antirhinoviral activity of heterocyclic analogs of Win 54954.
Bailey TR; Diana GD; Kowalczyk PJ; Akullian V; Eissenstat MA; Cutcliffe D; Mallamo JP; Carabateas PM; Pevear DC
J Med Chem; 1992 Nov; 35(24):4628-33. PubMed ID: 1335079
[TBL] [Abstract][Full Text] [Related]
5. Synthesis and antirhinovirus activity of 3-(diethylamino)-5-phenylisoxazole derivatives.
Mazzei M; Garzoglio R; Balbi A; Grandi T; De Montis A; Corrias S; La Colla P
Farmaco; 1996 May; 51(5):351-9. PubMed ID: 8767845
[TBL] [Abstract][Full Text] [Related]
6. Disoxaril-related 3-(diethylamino)-5-phenylisoxazoles.
Mazzei M; Dondero R; Ledda B; Demontis F; Vargiu L
Farmaco; 2000 Feb; 55(2):119-24. PubMed ID: 10782382
[TBL] [Abstract][Full Text] [Related]
7. Enantiomeric effects of homologues of disoxaril on the inhibitory activity against human rhinovirus-14.
Diana GD; Otto MJ; Treasurywala AM; McKinlay MA; Oglesby RC; Maliski EG; Rossmann MG; Smith TJ
J Med Chem; 1988 Mar; 31(3):540-4. PubMed ID: 2831362
[TBL] [Abstract][Full Text] [Related]
8. New pleconaril and [(biphenyloxy)propyl]isoxazole derivatives with substitutions in the central ring exhibit antiviral activity against pleconaril-resistant coxsackievirus B3.
Schmidtke M; Wutzler P; Zieger R; Riabova OB; Makarov VA
Antiviral Res; 2009 Jan; 81(1):56-63. PubMed ID: 18840470
[TBL] [Abstract][Full Text] [Related]
9. CoMFA analysis of the interactions of antipicornavirus compounds in the binding pocket of human rhinovirus-14.
Diana GD; Kowalczyk P; Treasurywala AM; Oglesby RC; Pevear DC; Dutko FJ
J Med Chem; 1992 Mar; 35(6):1002-8. PubMed ID: 1313108
[TBL] [Abstract][Full Text] [Related]
10. An evaluation of the antirhinoviral activity of acetylfuran replacements for 3-methylisoxazoles. Are 2-acetylfurans bioisosteres for 3-methylisoxazoles?
Bailey TR; Diana GD; Mallamo JP; Vescio N; Draper TL; Carabateas PM; Long MA; Giranda VL; Dutko FJ; Pevear DC
J Med Chem; 1994 Nov; 37(24):4177-84. PubMed ID: 7990117
[TBL] [Abstract][Full Text] [Related]
11. Novel pleconaril derivatives: Influence of substituents in the isoxazole and phenyl rings on the antiviral activity against enteroviruses.
Egorova A; Kazakova E; Jahn B; Ekins S; Makarov V; Schmidtke M
Eur J Med Chem; 2020 Feb; 188():112007. PubMed ID: 31881489
[TBL] [Abstract][Full Text] [Related]
12. [[[(Thienylcarbonyl)alkyl]oxy]phenyl]- and [[[(pyrrylcarbonyl)alkyl]oxy]phenyl]oxazoline derivatives with potent and selective antihuman rhinovirus activity.
Massa S; Corelli F; Artico M; Mai A; Ragno R; De Montis A; Loi AG; Corrias S; Marongiu ME; La Colla P
J Med Chem; 1995 Mar; 38(5):803-9. PubMed ID: 7877145
[TBL] [Abstract][Full Text] [Related]
13. Synthesis and anti-HIV activity of a new isoxazole containing disubstituted 1,2,4-oxadiazoles analogs.
Kumar Kushwaha P; Saurabh Srivastava K; Kumari N; Kumar R; Mitra D; Sharon A
Bioorg Med Chem; 2022 Feb; 56():116612. PubMed ID: 35026631
[TBL] [Abstract][Full Text] [Related]
14. Structure-activity studies of 5-[[4-(4,5-dihydro-2-oxazolyl) phenoxy]alkyl]-3-methylisoxazoles: inhibitors of picornavirus uncoating.
Diana GD; Oglesby RC; Akullian V; Carabateas PM; Cutcliffe D; Mallamo JP; Otto MJ; McKinlay MA; Maliski EG; Michalec SJ
J Med Chem; 1987 Feb; 30(2):383-8. PubMed ID: 3027340
[TBL] [Abstract][Full Text] [Related]
15. Synthesis and evaluation of antirhinovirus activity of 3-hydroxy and 3-methoxy 2-styrylchromones.
Desideri N; Mastromarino P; Conti C
Antivir Chem Chemother; 2003 Jul; 14(4):195-203. PubMed ID: 14582848
[TBL] [Abstract][Full Text] [Related]
16. 9-Benzyl-6-(dimethylamino)-9H-purines with antirhinovirus activity.
Kelley JL; Linn JA; Krochmal MP; Selway JW
J Med Chem; 1988 Oct; 31(10):2001-4. PubMed ID: 2845083
[TBL] [Abstract][Full Text] [Related]
17. Quantitative structure-activity relationship studies of [(biphenyloxy)propyl]isoxazole derivatives. Inhibitors of human rhinovirus 2 replication.
Kuz'min VE; Artemenko AG; Muratov EN; Volineckaya IL; Makarov VA; Riabova OB; Wutzler P; Schmidtke M
J Med Chem; 2007 Aug; 50(17):4205-13. PubMed ID: 17665898
[TBL] [Abstract][Full Text] [Related]
18. A comparative test of fifteen compounds against all known human rhinovirus serotypes as a basis for a more rational screening program.
Andries K; Dewindt B; Snoeks J; Willebrords R; Stokbroekx R; Lewi PJ
Antiviral Res; 1991 Oct; 16(3):213-25. PubMed ID: 1666824
[TBL] [Abstract][Full Text] [Related]
19. Synthesis and structure-activity relationships of 3,5-diarylisoxazoles and 3,5-diaryl-1,2,4-oxadiazoles, novel classes of small molecule interleukin-8 (IL-8) receptor antagonists.
Weidner-Wells MA; Henninger TC; Fraga-Spano SA; Boggs CM; Matheis M; Ritchie DM; Argentieri DC; Wachter MP; Hlasta DJ
Bioorg Med Chem Lett; 2004 Aug; 14(16):4307-11. PubMed ID: 15261292
[TBL] [Abstract][Full Text] [Related]
20. Binding affinities of structurally related human rhinovirus capsid-binding compounds are related to their activities against human rhinovirus type 14.
Fox MP; McKinlay MA; Diana GD; Dutko FJ
Antimicrob Agents Chemother; 1991 Jun; 35(6):1040-7. PubMed ID: 1656851
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
